Impact of Age on Clinical Outcomes Following Left Atrial Appendage Occlusion: A Meta-Analysis And Systematic Review of Observational Studies

Left atrial appendage occlusion (LAAO) offers an alternative to oral anticoagulation for stroke prevention in patients with non-valvular atrial fibrillation; however, the impact of advanced age on outcomes remains uncertain. We conducted a systematic review and meta-analysis to evaluate the effect of age on in-hospital and long-term outcomes following LAAO. A comprehensive search of PubMed and Google Scholar yielded 1,372 studies, of which seven met the inclusion criteria after screening and full-text review. Eligible studies stratified outcomes by age (<75 vs ≥75, <80 vs ≥80, or multilevel age groups), and we analyzed all-cause mortality, stroke/systemic embolism (SE), and major bleeding using relative risks (RRs) with 95% confidence intervals (CI). Long-term mortality was significantly higher among older patients, with mortality rising from 32.4% at age 65-69 to 63.4% in those ≥85 (RR 1.96, 95%CI 1.90-2.03), and from 14.3% <80 to 38.8% ≥80 (RR 2.71, 95%CI 2.24-3.28). Pooled analysis demonstrated substantial heterogeneity for mortality (I² = 80.7%). Stroke/SE rates were modestly elevated with age, including 13.0% in ≥85 vs 5.3% at 65-69 (RR 2.45, 95%CI 2.00-3.00), with moderate heterogeneity across studies (I² = 63.9%). Major bleeding consistently increased in older groups, such as 18.4% ≥85 vs 12.0% at 65-69 (RR 1.53, 95%CI 1.35-1.72) and 22.6% ≥80 vs 12.1% <80 (RR 1.87, 95%CI 1.44-2.41), with high heterogeneity (I² = 83.4%). In-hospital mortality and stroke/SE were low overall but showed age-related increases in large cohorts. A funnel plot suggested no major publication bias. LAAO provides consistent stroke prevention across all ages, but older patients, particularly those ≥80-experience significantly higher mortality and bleeding risks. Age should not contraindicate LAAO but should guide individualized risk-benefit discussions, especially regarding bleeding management and long-term prognosis.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-12-06
DOI
https://doi.org/10.7759/cureus.98603
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Age on Clinical Outcomes Following Left Atrial Appendage Occlusion: A Meta-Analysis And Systematic Review of Observational Studies

Rakesh Prashad, Ibrahim O Abunemr, Amro Alseid
Cureus
Atrial Fibrillation Management and Outcomes
article

Impact of Age on Clinical Outcomes Following Left Atrial Appendage Occlusion: A Meta-Analysis And Systematic Review of Observational Studies

Rakesh Prashad, Ibrahim O Abunemr, Amro Alseid
article en

Abstract

Left atrial appendage occlusion (LAAO) offers an alternative to oral anticoagulation for stroke prevention in patients with non-valvular atrial fibrillation; however, the impact of advanced age on outcomes remains uncertain. We conducted a systematic review and meta-analysis to evaluate the effect of age on in-hospital and long-term outcomes following LAAO. A comprehensive search of PubMed and Google Scholar yielded 1,372 studies, of which seven met the inclusion criteria after screening and full-text review. Eligible studies stratified outcomes by age (<75 vs ≥75, <80 vs ≥80, or multilevel age groups), and we analyzed all-cause mortality, stroke/systemic embolism (SE), and major bleeding using relative risks (RRs) with 95% confidence intervals (CI). Long-term mortality was significantly higher among older patients, with mortality rising from 32.4% at age 65-69 to 63.4% in those ≥85 (RR 1.96, 95%CI 1.90-2.03), and from 14.3% <80 to 38.8% ≥80 (RR 2.71, 95%CI 2.24-3.28). Pooled analysis demonstrated substantial heterogeneity for mortality (I² = 80.7%). Stroke/SE rates were modestly elevated with age, including 13.0% in ≥85 vs 5.3% at 65-69 (RR 2.45, 95%CI 2.00-3.00), with moderate heterogeneity across studies (I² = 63.9%). Major bleeding consistently increased in older groups, such as 18.4% ≥85 vs 12.0% at 65-69 (RR 1.53, 95%CI 1.35-1.72) and 22.6% ≥80 vs 12.1% <80 (RR 1.87, 95%CI 1.44-2.41), with high heterogeneity (I² = 83.4%). In-hospital mortality and stroke/SE were low overall but showed age-related increases in large cohorts. A funnel plot suggested no major publication bias. LAAO provides consistent stroke prevention across all ages, but older patients, particularly those ≥80-experience significantly higher mortality and bleeding risks. Age should not contraindicate LAAO but should guide individualized risk-benefit discussions, especially regarding bleeding management and long-term prognosis.

CureusVol. 17(12)
University of Jordan (JO), College of Central Florida (US)
Openalex Percentile: Top 44%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Impact of Age on Clinical Outcomes Following Left Atrial Appendage Occlusion: A Meta-Analysis And Systematic Review of Observational Studies — Rakesh Prashad, Ibrahim O Abunemr, et al. · Cureus (2025) | TGRS Research Map | TGRS